[
  {
    "ts": null,
    "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
    "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
    "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736791802,
      "headline": "Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025",
      "id": 132390023,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1886168184/image_1886168184.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive opportunities for investors.",
      "url": "https://finnhub.io/api/news?id=5893587e5fa3e91a37b6975c5ceac34f7fc311555b4dc90278e6109cce22d835"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock underperforms Monday when compared to competitors",
    "summary": "Eli Lilly & Co. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=5ca1a4ed02d4da6be717721fe376a6df28d2c8195225538227c87b1676a40ab6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736785860,
      "headline": "Eli Lilly & Co. stock underperforms Monday when compared to competitors",
      "id": 132407710,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=5ca1a4ed02d4da6be717721fe376a6df28d2c8195225538227c87b1676a40ab6"
    }
  },
  {
    "ts": null,
    "headline": "Lilly asks US government to pause drug price negotiation program, Bloomberg News reports",
    "summary": "Eli Lilly has asked the U.S. government to pause the new law that allows Medicare to negotiate prices for its costliest prescription drugs, Bloomberg News reported on Monday, citing Lilly Chief...",
    "url": "https://finnhub.io/api/news?id=8d5363c04f4ac503e8c1f4f1f91767a7954bed52c7f7e6227e84c0634341443a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736775043,
      "headline": "Lilly asks US government to pause drug price negotiation program, Bloomberg News reports",
      "id": 132388911,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly has asked the U.S. government to pause the new law that allows Medicare to negotiate prices for its costliest prescription drugs, Bloomberg News reported on Monday, citing Lilly Chief...",
      "url": "https://finnhub.io/api/news?id=8d5363c04f4ac503e8c1f4f1f91767a7954bed52c7f7e6227e84c0634341443a"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson makes $15 billion bet on mental-health drugs",
    "summary": "Johnson & Johnson makes $15 billion bet on mental-health drugs",
    "url": "https://finnhub.io/api/news?id=35f7f11489d2dd65b5f0ad8661db1e6bbf02ca68fe03f5836e3199a0176a3619",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736770500,
      "headline": "Johnson & Johnson makes $15 billion bet on mental-health drugs",
      "id": 132407711,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson makes $15 billion bet on mental-health drugs",
      "url": "https://finnhub.io/api/news?id=35f7f11489d2dd65b5f0ad8661db1e6bbf02ca68fe03f5836e3199a0176a3619"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing",
    "summary": "-- Eli Lilly & Co. Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill...",
    "url": "https://finnhub.io/api/news?id=c0192b18c69c77dbed4053a7ccb4ceb9486136b502394ca0f58a4e1683eb0aab",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736767814,
      "headline": "Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing",
      "id": 132388335,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "-- Eli Lilly & Co. Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by Scorpion Therapeutics. He also says Lilly's experimental weight-loss pill...",
      "url": "https://finnhub.io/api/news?id=c0192b18c69c77dbed4053a7ccb4ceb9486136b502394ca0f58a4e1683eb0aab"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
    "summary": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
    "url": "https://finnhub.io/api/news?id=37e2a928d2167d0048035cc98a3a4b5233aa2bc53c699711f8e55cded28f8379",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736765823,
      "headline": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
      "id": 132407688,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.",
      "url": "https://finnhub.io/api/news?id=37e2a928d2167d0048035cc98a3a4b5233aa2bc53c699711f8e55cded28f8379"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly to Buy Scorpion Therapeutics Drug Program in $2.5 Billion Deal",
    "summary": "By Dean Seal Eli Lilly has agreed to acquire Scorpion Therapeutics' breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its...",
    "url": "https://finnhub.io/api/news?id=b4d6b630aea349230b76c62667f7c5434d3de1e21939f5ac7e41499d94026c21",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736760909,
      "headline": "Eli Lilly to Buy Scorpion Therapeutics Drug Program in $2.5 Billion Deal",
      "id": 132387702,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "By Dean Seal Eli Lilly has agreed to acquire Scorpion Therapeutics' breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its...",
      "url": "https://finnhub.io/api/news?id=b4d6b630aea349230b76c62667f7c5434d3de1e21939f5ac7e41499d94026c21"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: purchase of Scorpion Therapeutics' PI3Kα program",
    "summary": "Eli Lilly and Company announces the acquisition of Scorpion Therapeutics' PI3Kα program, including the inhibitor STX-478, an oral treatment in Phase 1/2 clinical trials for breast cancer and other...",
    "url": "https://finnhub.io/api/news?id=3942ad2b0249c7d4ba7f46b080d5d9e25f15e9d204f2e507588da2e4a2478091",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736760734,
      "headline": "Eli Lilly: purchase of Scorpion Therapeutics' PI3Kα program",
      "id": 132387679,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "Eli Lilly and Company announces the acquisition of Scorpion Therapeutics' PI3Kα program, including the inhibitor STX-478, an oral treatment in Phase 1/2 clinical trials for breast cancer and other...",
      "url": "https://finnhub.io/api/news?id=3942ad2b0249c7d4ba7f46b080d5d9e25f15e9d204f2e507588da2e4a2478091"
    }
  },
  {
    "ts": null,
    "headline": "Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program",
    "summary": "The acquisition will expand Lilly's oncology pipeline with STX-478, the differentiated and potentially best-in-class, mutant-selective PI3Kα inhibitor currently in a Phase 1/2 clinical trialSTX-478...",
    "url": "https://finnhub.io/api/news?id=fd6c67f599c53850e71165bf0b1d0783e8fac6508a03861312cbaa037cc28ec4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736758874,
      "headline": "Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program",
      "id": 132387515,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "The acquisition will expand Lilly's oncology pipeline with STX-478, the differentiated and potentially best-in-class, mutant-selective PI3Kα inhibitor currently in a Phase 1/2 clinical trialSTX-478...",
      "url": "https://finnhub.io/api/news?id=fd6c67f599c53850e71165bf0b1d0783e8fac6508a03861312cbaa037cc28ec4"
    }
  },
  {
    "ts": null,
    "headline": "The Market Is Likely Wrong About Trump And Inflation - Here's Why",
    "summary": "Discover the potential impact of Trump's policies on inflation and get actionable stock picks for your portfolio in this insightful financial article. Read more here.",
    "url": "https://finnhub.io/api/news?id=71481f0697c2d13c237fc8125cad2dac593e4cb4af98392f3aa89e383b551ef0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736751671,
      "headline": "The Market Is Likely Wrong About Trump And Inflation - Here's Why",
      "id": 132386825,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2174056394/image_2174056394.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Discover the potential impact of Trump's policies on inflation and get actionable stock picks for your portfolio in this insightful financial article. Read more here.",
      "url": "https://finnhub.io/api/news?id=71481f0697c2d13c237fc8125cad2dac593e4cb4af98392f3aa89e383b551ef0"
    }
  }
]